ENDRA Life Sciences Inc. 4/A
4/A · ENDRA Life Sciences Inc. · Filed May 23, 2017
Insider Transaction Report
Form 4/AAmended
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2017-05-12+6,000→ 6,000 totalExercise: $5.00From: 2017-05-12Exp: 2025-05-12→ Common Stock (6,000 underlying) - Award
Stock Options
2017-05-12+6,000→ 6,000 totalExercise: $5.00From: 2017-12-31Exp: 2025-05-12→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The correct expiration date is May 12, 2025.
- [F2]This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017.